2024 Q4 Portfolio Activity
In 2024 Q4, Altitude Crest Partners Inc. maintained a portfolio of 30 distinct positions. They heavily accumulated shares in ALIGOS THERAPEUTICS INC, increasing the position by 610.4%. The fund also reduced its exposure to ALIGOS THERAPEUTICS INC by 85.9%.
Position History
hover any row below to update
Loading…
Total Positions
30
Quarter
2024 Q4
Top Holding
LEGN (15.7%)
Top 10 Concentration
69.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-30 of 30
Altitude Crest Partners Inc. Full Holdings List — 2024 Q4
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 15.67% | 15.67% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
652,732 | $36,611,738 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
DHR
DANAHER CORPORA...
|
Healthcare | 11.62% | 11.62% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
108,700 | $27,144,564 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 8.10% | 8.10% |
#3
Prev: #3
|
5.2 |
—
|
no change | no change |
P
S
|
612,060 | $18,924,895 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
STVN
STEVANATO GROUP...
|
Healthcare | 7.56% | 7.56% |
#4
Prev: #4
|
4.5 |
—
|
no change | no change |
P
S
|
550,000 | $17,655,000 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 7.23% | 7.23% |
#5
Prev: #5
|
4.4 |
—
|
no change | no change |
P
S
|
287,277 | $16,886,142 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 4.58% | 4.58% |
#6
Prev: #6
|
2.8 |
—
|
no change | no change |
P
S
|
18,400 | $10,694,264 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 4.25% | 4.25% |
#7
Prev: #7
|
2.7 |
—
|
no change | no change |
P
S
|
555,555 | $9,922,212 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 3.76% | 3.76% |
#8
Prev: #8
|
2.5 |
—
|
no change | no change |
P
S
|
205,166 | $8,793,415 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
N/A
KINIKSA PHARMAC...
|
|
Unknown | 3.38% | 3.38% |
#9
Prev: #9
|
2.4 |
—
|
no change | no change |
P
S
|
400,441 | $7,900,701 | — | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | ||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 3.12% | 3.12% |
#10
Prev: #10
|
2.2 |
—
|
no change | no change |
P
S
|
193,300 | $7,277,745 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 3.06% | 3.06% |
#11
Prev: #11
|
2.2 |
—
|
no change | no change |
P
S
|
9,200 | $7,157,232 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 2.77% | 2.77% |
#12
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
118,380 | $6,474,202 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 2.77% | 2.77% |
#13
Prev: #13
|
2.1 |
—
|
no change | no change |
P
S
|
262,284 | $6,473,169 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SWTX
SPRINGWORKS THE...
|
Unknown | 2.71% | 2.71% |
#14
Prev: #14
|
2.1 |
—
|
no change | no change |
P
S
|
128,842 | $6,341,603 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
GERN
GERON CORP
|
Healthcare | 2.16% | 2.16% |
#15
Prev: #15
|
1.9 |
—
|
no change | no change |
P
S
|
1,531,400 | $5,053,620 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ICLR
ICON PLC
|
Healthcare | 2.13% | 2.13% |
#16
Prev: #16
|
1.9 |
—
|
no change | no change |
P
S
|
14,800 | $4,972,060 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 2.12% | 2.12% |
#17
Prev: #17
|
1.8 |
—
|
no change | no change |
P
S
|
109,837 | $4,945,960 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 2.05% | 2.05% |
#18
Prev: #18
|
1.8 |
—
|
no change | no change |
P
S
|
454,766 | $4,793,234 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.84% | 1.84% |
#19
Prev: #19
|
1.7 |
—
|
no change | no change |
P
S
|
209,613 | $4,301,259 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.74% | 1.74% |
#20
Prev: #20
|
1.7 |
—
|
no change | no change |
P
S
|
103,703 | $4,069,306 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.42% | 1.42% |
#21
Prev: #21
|
1.6 |
—
|
no change | no change |
P
S
|
113,100 | $3,307,044 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 1.38% | 1.38% |
#22
Prev: #22
|
1.6 |
—
|
no change | no change |
P
S
|
195,497 | $3,229,610 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
N/A
ALIGOS THERAPEU...
|
|
Unknown | 1.19% | 1.19% |
#23
Prev: #23
|
1.5 |
—
|
no change | no change |
P
S
|
2,844,681 | $2,787,787 | — | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | ||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 0.87% | 0.87% |
#24
Prev: #24
|
1.3 |
—
|
no change | no change |
P
S
|
120,289 | $2,038,899 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
APLT
APPLIED THERAPE...
|
Healthcare | 0.76% | 0.76% |
#25
Prev: #25
|
1.3 |
—
|
no change | no change |
P
S
|
259,700 | $1,765,960 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 0.66% | 0.66% |
#26
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
145,581 | $1,531,512 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
MGX
METAGENOMI INC
|
Healthcare | 0.60% | 0.60% |
#27
Prev: #27
|
1.2 |
—
|
no change | no change |
P
S
|
133,333 | $1,406,663 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TRML
TOURMALINE BIO ...
|
Unknown | 0.46% | 0.46% |
#28
Prev: #28
|
1.2 |
—
|
no change | no change |
P
S
|
47,400 | $1,085,460 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.01% | 0.01% |
#29
Prev: #29
|
1.0 |
—
|
no change | no change |
P
S
|
200 | $29,890 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SRZNW
SURROZEN INC
|
Unknown | 0.01% | 0.01% |
#30
Prev: #30
|
1.0 |
—
|
no change | no change |
P
S
|
384,573 | $12,499 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) |
Showing 1-30 of 30 holdings